Authors :
Haniya Jabeen; Aqsa Fatima; Fatima Umaira Saeed
Volume/Issue :
Volume 9 - 2024, Issue 4 - April
Google Scholar :
https://tinyurl.com/3ndc7rv8
Scribd :
https://tinyurl.com/584n8h3a
DOI :
https://doi.org/10.38124/ijisrt/IJISRT24APR1374
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Abstract :
Emerging as a WHO priority pathogen,
Nipah virus (NiV) – an RNA virus within the
Paramyxoviridae family – first ignited outbreaks in 1998
Malaysia. Closely related to Hendra virus, NiV continues
to threaten South and Southeast Asia. A zoonotic threat,
Nipah virus (NiV) jumps from its natural reservoir, fruit
bats, to pigs and then humans. This BSL-4 threat, with
no cure or shield, compels us to harmonise the voices of
humans, animals, and the environment in a One Health
symphony to prevent future outbreaks. A 2018 Chinese
study identified populations at high risk for Nipah virus
infection are Fruit farmers, traders, palm wine brewers,
Cattle herders, especially pig farmers and Tourists.
Nipah virus exhibits remarkable zoonotic versatility,
with transmission pathways between humans and
animals varying based on geography. Factors such as
diverse livestock breeding practices, local eating habits,
and the interplay with the natural reservoir - fruit bats -
contribute to this fascinating mosaic of infection routes.
Unravelling these complexities is crucial for designing
effective control strategies tailored to specific regions.
Following exposure to the Nipah virus (NiV), symptoms
typically appear within two weeks, ranging from 4 days
to 2 months. Fever, headache, dizziness, and vomiting
are common initial signs, potentially progressing to
severe encephalitis. A promising development in the
fight against Nipah virus emerges as the National
Institute of Allergy and Infectious Diseases (NIAID)
initiates an early-phase clinical trial for an
investigational vaccine.
Emerging as a WHO priority pathogen,
Nipah virus (NiV) – an RNA virus within the
Paramyxoviridae family – first ignited outbreaks in 1998
Malaysia. Closely related to Hendra virus, NiV continues
to threaten South and Southeast Asia. A zoonotic threat,
Nipah virus (NiV) jumps from its natural reservoir, fruit
bats, to pigs and then humans. This BSL-4 threat, with
no cure or shield, compels us to harmonise the voices of
humans, animals, and the environment in a One Health
symphony to prevent future outbreaks. A 2018 Chinese
study identified populations at high risk for Nipah virus
infection are Fruit farmers, traders, palm wine brewers,
Cattle herders, especially pig farmers and Tourists.
Nipah virus exhibits remarkable zoonotic versatility,
with transmission pathways between humans and
animals varying based on geography. Factors such as
diverse livestock breeding practices, local eating habits,
and the interplay with the natural reservoir - fruit bats -
contribute to this fascinating mosaic of infection routes.
Unravelling these complexities is crucial for designing
effective control strategies tailored to specific regions.
Following exposure to the Nipah virus (NiV), symptoms
typically appear within two weeks, ranging from 4 days
to 2 months. Fever, headache, dizziness, and vomiting
are common initial signs, potentially progressing to
severe encephalitis. A promising development in the
fight against Nipah virus emerges as the National
Institute of Allergy and Infectious Diseases (NIAID)
initiates an early-phase clinical trial for an
investigational vaccine.
